A head-to-head trial found that tirzepatide led to significantly greater weight loss and waist reduction than semaglutide in ...

Compounded tirzepatide contains the same active ingredient ... Your doctor may increase your dosage in increments up to a maximum dose of 15 mg once weekly. Some symptoms were severe enough ...

Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than did semaglutide (trade name Wegovy) in a clinical trial that compared the safety and efficacy of the ...

The SURMOUNT-5 trial, published over the weekend in the New England Journal of Medicine and presented at the European Congress on Obesity, showed that treatment with tirzepatide (Zepbound; Eli Lilly) ...

The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published, examining their ability to reduce weight and waist circumference.

Semaglutide and tirzepatide prescriptions for obesity are influenced by race, gender, social vulnerability, and urbanicity, with disparities in access and utilization. Despite increased ...

Jaime Almandoz, MD, MBA, of UT Southwestern Medical Center, speaks on results of a study that investigated tirzepatide uptake trends in commercial claims data. A recent article published in Annals ...

A new study says that people who use tirzepatide lose more weight than people who use semaglutide Cara Lynn Shultz is a writer-reporter at PEOPLE. Her work has previously appeared in Billboard and ...

Researchers at the Pennington Biomedical Research Center conducted a first-of-its-kind study to provide insights into the mechanisms of action of tirzepatide – a drug known as Zepbound™ – on weight ...

Late last year, the FDA approved tirzepatide (Zepbound, Eli Lilly) for adults with moderate to severe obstructive sleep apnea and obesity after the medication showed significantly more efficacy vs.